Nautilus Biotechnology, Inc.

NAUT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$71-$64-$58-$50
Dep. & Amort.$6$6$3$3
Deferred Tax$0$0$0$0
Stock-Based Comp.$13$12$10$8
Change in WC-$5-$3-$1-$0
Other Non-Cash-$2-$3-$1$0
Operating Cash Flow-$59-$52-$46-$39
Investing Activities
PP&E Inv.-$2-$2-$2-$2
Net Acquisitions$0$0$0$0
Inv. Purchases-$86-$113-$187-$222
Inv. Sales/Matur.$0$72$163$85
Other Inv. Act.$155$0$0$0
Investing Cash Flow$66-$44-$26-$139
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1$0$1-$8
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$335
Financing Cash Flow$1$0$1$327
Forex Effect$0$0$0$0
Net Chg. in Cash$8-$95-$71$149
Supplemental Information
Beg. Cash$20$115$186$37
End Cash$29$20$115$186
Free Cash Flow-$61-$54-$48-$42